Insurance Pharmaceutical Problem-Solving 
Insperity
AUGUST 9, 2018
When the mandates of the Affordable Care Act hit the marketplace in 2013, for example, insurance brokers nationwide were challenged with delivering additional value to their customers to offset rising healthcare costs for employers. It also allows you to create more authority in your area of expertise. A strategy for success.
Mad in America
MAY 10, 2025
Once again, a pharmaceutical had altered an essential part of my body. Countless supplements and over 30 different pharmaceuticals, I pretty much tried it all. This is the biggest problem I see with psychiatryit is largely based on outdated models and a lot of pseudoscience. I started freaking out.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
JUNE 5, 2025
Psychologists were leading discussions, therapists were guiding treatment, and even insurance companies were funding itreluctantly. The messiness of human suffering was sorted into categories, each with a matching pharmaceutical solution. Insurance companies embraced the new model. It was a triumph of efficiency.
Mad in America
DECEMBER 13, 2023
You sent some great questions and on this and our next podcast, we will be talking with Bob about Mad in America, the biopsychosocial model, the history of psychiatry, pharmaceutical marketing, and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. Whitaker: Here’s the problem in psychiatry today.
Mad in America
MAY 15, 2024
I pushed away thoughts like, “What’s the point of giving a drug to solve a quality of life problem?” Siem: You don’t serve the pharmaceutical company who might be paying you on the side. I have a lot of patients that come to me—especially male—who say, they have a problem with anger. You don’t serve the CEO.
Success
FEBRUARY 15, 2022
Through the four businesses she has founded, which span strategic services, design, construction and events, Burgess helps solve problems for good and create spaces and events that make you feel happy. She is a problem solver, a solution maven, and an avid investor in emerging brands and creator of her own CPG brands. .
Mad in America
FEBRUARY 12, 2025
Thats not a leap people often makefrom philosophical psychology to critiques of the pharmaceutical industry and medicalization. She was deeply involved in critical psychiatry and critiques of the pharmaceutical industry. Together, we drafted an open letter laying out the problems with the DSM-5.
Expert insights. Personalized for you.
223 
Let's personalize your content